ADVFN US – Market Content Editor

  • Datavault AI Q2 Revenue Jumps 287% as Tokenization Platform Moves Toward Commercialization

    Datavault AI Q2 Revenue Jumps 287% as Tokenization Platform Moves Toward Commercialization

    Datavault AI reported $6.7 million in second-quarter revenue and maintained its target of at least $200 million for 2026, putting execution and the conversion of commercial opportunities into recognised revenue firmly in focus. Key Investor Takeaways Why DVLT Stock Is in Focus Datavault AI (NASDAQ:DVLT) delivered 287% year-over-year Q2 revenue growth as it continued assembling…

  • Eshallgo Secures Exclusive North American Distribution Partnership With Zhongshan Senwei

    Eshallgo Secures Exclusive North American Distribution Partnership With Zhongshan Senwei

    Eshallgo’s California subsidiary will exclusively distribute Zhongshan Senwei printing consumables in North America, initially targeting major e-commerce channels as the company builds its overseas operations. Key Investor Takeaways Why EHGO Stock Is in Focus Eshallgo (NASDAQ:EHGO) is expanding its North American strategy through an exclusive distribution agreement between its wholly owned California subsidiary and Zhongshan…

  • IQSTEL First-Half Revenue Jumps 59% as Digital Services Strategy Takes Focus

    IQSTEL First-Half Revenue Jumps 59% as Digital Services Strategy Takes Focus

    IQSTEL generated $207 million in first-half revenue while gross profit growth lagged the top-line increase, putting margin expansion and its $430 million full-year target in focus. Key Investor Takeaways Why IQST Stock Is in Focus IQSTEL (NASDAQ:IQST) delivered 59% year-over-year first-half revenue growth, taking sales to $207 million from approximately $130 million a year earlier.…

  • Lowe’s Cuts Full-Year Sales Outlook as DIY Spending Remains Under Pressure

    Lowe’s Cuts Full-Year Sales Outlook as DIY Spending Remains Under Pressure

    Lowe’s (NYSE:LOW) has lowered its full-year sales forecast as persistent weakness in spending on major home improvement projects continues to weigh on the retailer, with CEO Marvin Ellison pointing to a challenging environment for discretionary DIY purchases. Shares of Lowe’s fell more than 2% in Wednesday premarket trading following the updated outlook. High interest rates…

  • Target Raises Full-Year Sales Outlook as Turnaround Efforts Gain Traction

    Target Raises Full-Year Sales Outlook as Turnaround Efforts Gain Traction

    Target (NYSE:TGT) has increased its annual sales forecast for a second consecutive quarter, offering further signs that the retailer’s turnaround strategy under new CEO Michael Fiddelke may be beginning to deliver results. Excluding the impact of a tariff refund, Target now expects full-year earnings per share to be $0.75 higher at the midpoint than its…

  • Analog Devices Rises as Third-Quarter Results and Q4 Forecast Top Estimates

    Analog Devices Rises as Third-Quarter Results and Q4 Forecast Top Estimates

    Analog Devices (NASDAQ:ADI) shares gained more than 1% in Wednesday premarket trading after the semiconductor company delivered better-than-expected fiscal third-quarter results and issued a fourth-quarter outlook above Wall Street forecasts, supported by strength in its data centre and industrial businesses. For the third quarter, Analog Devices reported earnings per share of $3.45, exceeding the analyst…

  • TJX Shares Fall as Third-Quarter Profit Forecast Misses Expectations

    TJX Shares Fall as Third-Quarter Profit Forecast Misses Expectations

    TJX (NYSE:TJX) shares fell around 4% in Wednesday premarket trading after the retailer issued a third-quarter earnings forecast below Wall Street expectations, overshadowing stronger-than-expected quarterly profit and an increase to its full-year guidance. For the second quarter, TJX reported earnings per share of $1.22, ahead of the $1.19 analyst consensus. Revenue reached $15.2 billion, broadly…

  • Moderna Shares Surge More Than 90% After Phase 3 Melanoma Trial Success

    Moderna Shares Surge More Than 90% After Phase 3 Melanoma Trial Success

    Moderna Inc (NASDAQ:MRNA) shares surged more than 90% in Wednesday pre-market trading after the biotechnology company and Merck (NYSE:MRK) reported positive Phase 3 results for their melanoma treatment combination, which performed better than Keytruda alone. The INTerpath-001 study evaluated intismeran autogene, an investigational mRNA-based individualised neoantigen therapy, in combination with Merck’s Keytruda in patients with…

  • US Antimony Shares Rise After Board Approves $100 Million Buyback

    US Antimony Shares Rise After Board Approves $100 Million Buyback

    United States Antimony Corporation (AMEX:UAMY) shares climbed 1.9% in Wednesday premarket trading after the company unveiled a new $100 million share repurchase programme. The company’s Board of Directors has authorised the repurchase of up to $100 million of outstanding common stock. The programme has no predetermined expiry date, giving the company flexibility to amend, pause…

  • Marvell Shares Surge After Google Warrant Deal Tied to Custom Chips

    Marvell Shares Surge After Google Warrant Deal Tied to Custom Chips

    Marvell Technology, Inc. (NASDAQ:MRVL) shares jumped nearly 11% in pre-market trading on Wednesday after the semiconductor company disclosed a warrant agreement with Google connected to an extensive custom silicon partnership. Under the agreement, dated Monday, Marvell granted Google a warrant giving it the right to acquire up to 58,970,907 shares of Marvell common stock at…